Ohio Public Employees Retirement System (OPERS)’s Kyverna Therapeutics KYTX Stock Holding History

Ohio Public Employees Retirement System (OPERS)’s Portfolio KYTX Stock Details KYTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-4,600	Closed	-$27.6K	–	2376
2025 Q3	$27.6K	Buy	+4,600	New	+$18.4K	﹤0.01%	2114
2025 Q2	–	Sell	-1,098	Closed	-$2.12K	–	2383
2025 Q1	$2.12K	Sell	1,098 -32,336	-97%	-$95.5K	﹤0.01%	2326
2024 Q4	$125K	Buy	+33,434	New	+$160K	﹤0.01%	1753

Other funds holding KYTX

GGI

GordonMD Global Investments Beverely Hills, California $144M AUM

Gilead Sciences Foster City, California $2.12B AUM 143.53% 1-Year Est. Return

BCLSI

Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

ACM

AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

IHG

Insight Holdings Group New York $1.42B AUM 41.03% 1-Year Est. Return

Ohio Public Employees Retirement System (OPERS)'s KYTX Position: Q4 2025 in Review

Ohio Public Employees Retirement System (OPERS) sold out of Kyverna Therapeutics (KYTX) in Q4 2025, closing a stake of 4,600 shares — an estimated $27.6K sold.

Ohio Public Employees Retirement System (OPERS) first reported a position in KYTX in Q4 2024 and held it in 3 quarters. The position peaked at $125K in Q4 2024. 99 funds tracked by Wall St. Rank hold KYTX as of Q4 2025.

Ohio Public Employees Retirement System (OPERS) reported no remaining Kyverna Therapeutics position as of Q4 2025 after selling out during the quarter.
Ohio Public Employees Retirement System (OPERS) sold 4,600 Kyverna Therapeutics shares in Q4 2025, an estimated $27.6K.
Ohio Public Employees Retirement System (OPERS) first reported a position in Kyverna Therapeutics in Q4 2024 and held it in 3 quarters.
Ohio Public Employees Retirement System (OPERS)'s Kyverna Therapeutics position peaked at $125K in Q4 2024.
99 funds tracked by Wall St. Rank held Kyverna Therapeutics as of Q4 2025.

Based on Ohio Public Employees Retirement System (OPERS)'s 13F filing for Q4 2025, filed 17 Feb 2026.